Delivery Order SPE2DB22D2206-SPE2DB25FDY47
Award Date
10/25/24
Potential Completion Date
10/28/24
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,065,463 units of the drug Cefepime-Dextrose 2 GM/50 MLS. The contract has a ceiling value of $25,324.95 and a period of performance through October 10, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,171,074 units of the pharmaceutical product Cefepime-Dextrose 2 GM/50 MLS. The contract has a ceiling value of $3,653.65 and an ultimate completion date of April 5, 2024. This delivery order contract is part of a larger $999,999,999.00 indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $12,208.89 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,566,658,119 units of the drug Cefepime-Dextrose 2 GM/50 MLS. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,107,064 units of the pharmaceutical product CEFEPIME-DEXTROSE 2 GM/50 MLS. This $23,944.67 award has an ultimate completion date of March 29, 2024 and is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 awarded solely to Amerisourcebergen Drug Corp by DLA. The IDC serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,813.60 firm fixed-price delivery order is for the supply of Cefepime-Dextrose 2 gram/50 mL, a critical antibiotic medication. The contract has an ultimate completion date of October 29, 2024 and was awarded on October 28, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,981.40, is for the delivery of 4566759183 - CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 19, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award, valued at $1,038.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4566449785 CEFEPIME-DEXTROSE 2 GM/50 MLS, a medical product, with a completion date of November 18, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated with a Set-Aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,241.14 firm fixed-price delivery order is for the supply of the injectable medication Cefepime-Dextrose 2 GM/50 MLS. The contract has a completion date of December 12, 2024 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with a ceiling value of $1,332.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product, with a completion date of December 10, 2024. The contract is a Firm Fixed Price arrangement and was not designated with any set-aside requirements, indicating open...
This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Cefepime-Dextrose 2 grams/50 milliliters, a pharmaceutical product, to the U.S. government. The contract has a ceiling value of $9,182.97 and an ultimate completion date of June 17, 2024. It is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a part of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery...